+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

United States Interventional Neuroradiology Market Outlook to 2025

  • ID: 4668278
  • Report
  • November 2018
  • Region: United States
  • 82 pages
  • GlobalData

FEATURED COMPANIES

  • Cerenovus
  • Medtronic Plc
  • MIZUHO Co Ltd
  • Penumbra Inc
  • Stryker Corp
  • Terumo Corp
  • MORE
United States Interventional Neuroradiology Market Outlook to 2025

Summary

the new report, United States Interventional Neuroradiology Market Outlook to 2025, provides key market data on the United States Interventional Neuroradiology market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intracranial Stents, Neurovascular Accessory Devices, Neurovascular Coiling Assist Devices, Neurovascular Embolization Devices and Neurovascular Thrombectomy Devices.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Interventional Neuroradiology market segments - Intracranial Stents, Neurovascular Accessory Devices, Neurovascular Coiling Assist Devices, Neurovascular Embolization Devices and Neurovascular Thrombectomy Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Interventional Neuroradiology market.
  • Global corporate-level profiles of key companies operating within the United States Interventional Neuroradiology market.
  • Key players covered include Medtronic plc, Penumbra Inc, Stryker Corp and others.
Reasons to Buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cerenovus
  • Medtronic Plc
  • MIZUHO Co Ltd
  • Penumbra Inc
  • Stryker Corp
  • Terumo Corp
  • MORE
1 Table of Contents

2 Introduction
2.1 What Is This Report About?
2.2 Interventional Neuroradiology Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Interventional Neuroradiology Market, United States
3.1 Interventional Neuroradiology Market, United States, Revenue ($m), 2015-2025
3.1.1 Neurovascular Accessory Devices Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.3 Neurovascular Embolization Devices Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.4 Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Interventional Neuroradiology Market, United States, Volume (Units), 2015-2025
3.2.1 Neurovascular Accessory Devices Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Neurovascular Coiling Assist Devices Market, United States, Volume (Units), by Segment, 2015-2025
3.2.3 Neurovascular Embolization Devices Market, United States, Volume (Units), by Segment, 2015-2025
3.2.4 Neurovascular Thrombectomy Devices Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Interventional Neuroradiology Market, United States, Average Price ($), 2015-2025
3.4 Interventional Neuroradiology Market, United States, Distribution Share by Revenue ($m), 2017
3.5 Interventional Neuroradiology Market, United States, Company Share by Revenue ($m), 2017

4 Overview of Key Companies in United States, Interventional Neuroradiology Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Stryker Corp
4.2.1 Company Overview
4.3 Penumbra Inc
4.3.1 Company Overview
4.4 Terumo Corp
4.4.1 Company Overview
4.5 MIZUHO Co Ltd
4.5.1 Company Overview
4.6 Cerenovus
4.6.1 Company Overview

5 Interventional Neuroradiology Market Pipeline Products

6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 AxoGen Raises USD141.4 Million in Public Offering of Shares
6.1.2 AxoGen Raises USD41 Million in Public Offering of Shares

7 Recent Developments
7.1 Corporate Communications
7.1.1 Jul 10, 2018: Stryker announces organizational changes
7.1.2 Jul 10, 2018: AxoGen Names Lisa N. Colleran As Board Director
7.1.3 Jun 22, 2018: Johnson & Johnson Announces Retirement of Group Worldwide Chairman, Sandra E. Peterson
7.1.4 Jun 22, 2018: Johnson & Johnson Appoints Senior Leaders to Executive Committee
7.1.5 Jun 13, 2018: Prana to Commence Phase 1 Clinical Trial of PBT434 for Treatment of Parkinsonian Diseases
7.1.6 Jun 04, 2018: AxoGen Names Kaila Krum Vice President, Investor Relations and Corporate Development
7.1.7 May 21, 2018: AxoGen Names Karen Zaderej As Board Chairman
7.1.8 Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson
7.1.9 Dec 14, 2017: Cibiem Appoints William H. Kucheman to the Board of Directors
7.1.10 Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors
7.1.11 Nov 01, 2017: New Phase 1/2 Study Data for ALXN1210 as a Potential Future Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) to Be Presented at American Society of Hematology (ASH) Meeting
7.1.12 Oct 18, 2017: AxoGen Receives David J. Gury Company of the Year Award from BioFlorida
7.2 Financial Announcements
7.2.1 Jul 17, 2018: Johnson & Johnson Reports 2018 Second-Quarter Results
7.2.2 May 08, 2018: Penumbra Reports First Quarter 2018 Financial Results
7.2.3 Apr 30, 2018: AxoGen Announces 2018 First Quarter Financial Results
7.2.4 Apr 26, 2018: Stryker reports first quarter 2018 operating results
7.2.5 Apr 17, 2018: Johnson & Johnson Reports 2018 First-Quarter Results
7.2.6 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results
7.2.7 Feb 28, 2018: AxoGen Reports 2017 Fourth Quarter and Full Year Financial Results
7.2.8 Feb 27, 2018: Penumbra Reports Fourth Quarter and Full Year 2017 Financial Results
7.2.9 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017
7.2.10 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook
7.2.11 Jan 23, 2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results
7.2.12 Jan 22, 2018: Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test
7.2.13 Jan 09, 2018: Stryker provides 2017 preliminary net sales results
7.2.14 Jan 08, 2018: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue
7.2.15 Nov 07, 2017: Penumbra Reports Third Quarter 2017 Financial Results
7.2.16 Nov 01, 2017: AxoGen Reports 2017 Third Quarter Financial Results
7.2.17 Oct 26, 2017: Stryker reports third quarter 2017 results
7.2.18 Oct 17, 2017: Johnson & Johnson Reports 2017 Third-Quarter Results
7.3 Government and Public Interest
7.3.1 Jun 05, 2018: Johnson & Johnson Announces Progress Toward Health for Humanity Goals
7.4 Product News
7.4.1 Nov 20, 2017: AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day

8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact Us
8.4 Disclaimer

List of Tables
Table 1: Interventional Neuroradiology Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Interventional Neuroradiology Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Neurovascular Accessory Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Neurovascular Accessory Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Neurovascular Embolization Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 8: Neurovascular Embolization Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 9: Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 10: Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 11: Interventional Neuroradiology Market, United States, Volume (Units), 2015-2020
Table 12: Interventional Neuroradiology Market, United States, Volume (Units), 2021-2025
Table 13: Neurovascular Accessory Devices Market, United States, Volume (Units), 2015-2020
Table 14: Neurovascular Accessory Devices Market, United States, Volume (Units), 2021-2025
Table 15: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2015-2020
Table 16: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2021-2025
Table 17: Neurovascular Embolization Devices Market, United States, Volume (Units), 2015-2020
Table 18: Neurovascular Embolization Devices Market, United States, Volume (Units), 2021-2025
Table 19: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2015-2020
Table 20: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2021-2025
Table 21: Interventional Neuroradiology Market, United States, Average Price ($), 2015-2020
Table 22: Interventional Neuroradiology Market, United States, Average Price ($), 2021-2025
Table 23: Interventional Neuroradiology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 24: Interventional Neuroradiology Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 25: Interventional Neuroradiology Market Pipeline Products
Table 26: AxoGen Raises USD141.4 Million in Public Offering of Shares
Table 27: AxoGen Raises USD41 Million in Public Offering of Shares
Table 28: Total Number of Primary Research Participants, Neurology Devices Market, by Country

List of Figures
Figure 1: Interventional Neuroradiology Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Neurovascular Accessory Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Neurovascular Embolization Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 5: Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 6: Interventional Neuroradiology Market, United States, Volume (Units), 2015-2025
Figure 7: Neurovascular Accessory Devices Market, United States, Volume (Units), 2015-2025
Figure 8: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2015-2025
Figure 9: Neurovascular Embolization Devices Market, United States, Volume (Units), 2015-2025
Figure 10: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2015-2025
Figure 11: Interventional Neuroradiology Market, United States, Company Share (%) 2017
Note: Product cover images may vary from those shown
  • Medtronic Plc
  • Stryker Corp
  • Penumbra Inc
  • Terumo Corp
  • MIZUHO Co Ltd
  • Cerenovus
Note: Product cover images may vary from those shown
Adroll
adroll